Real-Life Treatment of Metastatic Colorectal Cancer with Regorafenib: A Single-Centre Review
Abstract
Share and Cite
Gotfrit, J.; Vickers, M.; Sud, S.; Asmis, T.; Cripps, C.; Goel, R.; Hsu, T.; Jonker, D.; Goodwin, R. Real-Life Treatment of Metastatic Colorectal Cancer with Regorafenib: A Single-Centre Review. Curr. Oncol. 2017, 24, 234-239. https://doi.org/10.3747/co.24.3562
Gotfrit J, Vickers M, Sud S, Asmis T, Cripps C, Goel R, Hsu T, Jonker D, Goodwin R. Real-Life Treatment of Metastatic Colorectal Cancer with Regorafenib: A Single-Centre Review. Current Oncology. 2017; 24(4):234-239. https://doi.org/10.3747/co.24.3562
Chicago/Turabian StyleGotfrit, J., M. Vickers, S. Sud, T. Asmis, C. Cripps, R. Goel, T. Hsu, D. Jonker, and R. Goodwin. 2017. "Real-Life Treatment of Metastatic Colorectal Cancer with Regorafenib: A Single-Centre Review" Current Oncology 24, no. 4: 234-239. https://doi.org/10.3747/co.24.3562
APA StyleGotfrit, J., Vickers, M., Sud, S., Asmis, T., Cripps, C., Goel, R., Hsu, T., Jonker, D., & Goodwin, R. (2017). Real-Life Treatment of Metastatic Colorectal Cancer with Regorafenib: A Single-Centre Review. Current Oncology, 24(4), 234-239. https://doi.org/10.3747/co.24.3562